相关实验视频

Updated: Jun 20, 2025

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

高强度间歇训练在实验大鼠中改善了特拉马多尔诱导的毒性和氧化应激

Najmeh Sadat Hosseini¹, Sara Shirazpour², Mahla Zangiabadizadeh¹

¹Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, IRN.

|July 18, 2024

概括

高强度间歇训练 (HIIT) 可能会保护脏免受慢性特拉马多尔 (TRA) 使用造成的损伤. HIIT逆转了生化和氧化压力标志物,这表明它可能是长期TRA患者未来的脏保护策略.

科学领域:

腎臟病學 (nephrology) 是一種醫學.
运动生理学运动生理学
药理学药理学是指药理学的学科.

背景情况:

特拉马多尔 (TRA) 是一种用于中度至重度疼痛的广泛使用的止痛药.
慢性使用和滥用TRA与损伤 (毒性) 有关.
运动训练显示出减轻器官损伤的潜力.

研究的目的:

研究高强度间歇训练 (HIIT) 对经过慢性TRA治疗的雄性大鼠功能的保护作用.
评估HIIT对生物化学标记,氧化应激和TRA诱导的病理的影响.

主要方法:

30只雄性Wistar大鼠被分为控制,运动 (HIIT),TRA和TRA+HIIT组.
测量包括血清IL-6,IL-10,脏组织MDA,TAC,GPx,SOD以及血清白蛋白,尿素和肌素.
对TRA诱导的损伤进行了组织病理学评估.

主要成果:

慢性TRA的使用增加了氧化应激 (MDA) 和损伤标志物 (尿素,肌素),同时降低了抗氧化能力 (TAC,GPx,SOD).
HIIT与TRA (EXE-TRA组) 结合,显著扭转了这些TRA诱导的负面影响.
TRA诱导损伤,由氨酸体和亡证明,HIIT似乎可以减轻这种情况.

结论:

慢性使用特拉马多尔是毒的,由生物化学和病理学发现证实.
高强度间歇训练显示出对抗TRA诱导的损伤的潜力.
对于接受长期特拉马多尔治疗的人来说,HIIT可能是潜在的脏保护策略.

关键词:

灭症 (apoptosis) 是一种死亡的过程.高强度间歇训练 (hiit) 是指高强度的间歇训练.这是一种炎症炎症炎症炎症.功能功能功能氧化应激是一种氧化应激.特拉马多尔 (Tramadol) 是一种药物.

更多相关视频

Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice

Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice

Published on: February 2, 2019

Activity-based Training on a Treadmill with Spinal Cord Injured Wistar Rats

Activity-based Training on a Treadmill with Spinal Cord Injured Wistar Rats

Published on: January 16, 2019

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...